Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Robert Dean Davies

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PSYCH
Phone303/724-2229
    Other Positions
    TitleAssoc Chair
    InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
    DepartmentSOM-PSYCH
    DivisionGeneral Operations


    Collapse Research 
    Collapse research activities and funding
    R01DA018679     (DAVIES, ROBERT D)May 1, 2006 - Apr 30, 2010
    NIH
    Martial Arts As Early Intervention for Teen Drug Abuse
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hoffner-Heinike A, Iwamoto SJ, Saxon DR, Cogdall NA, Davies RD, Lee RS, Chiappone A, Thomas JF, Rothman MS. ECHO "Bootcamp": An Innovative Training Model to Onboard Providers in the Care of Gender Diverse Patients. Telemed J E Health. 2024 Feb; 30(2):430-437. PMID: 37499094.
      View in: PubMed
    2. Iwamoto SJ, Defreyne J, Kaoutzanis C, Davies RD, Moreau KL, Rothman MS. Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults. Ther Adv Endocrinol Metab. 2023; 14:20420188231166494. PMID: 37113210.
      View in: PubMed
    3. Davies RD, Davies ME. The (Slow) Depathologizing of Gender Incongruence. J Nerv Ment Dis. 2020 02; 208(2):152-154. PMID: 31977826.
      View in: PubMed
    4. Scott JS, Bailey A, Buttar D, Carbajo RJ, Curwen J, Davey PRJ, Davies RDM, Degorce SL, Donald C, Gangl E, Greenwood R, Groombridge SD, Johnson T, Lamont S, Lawson M, Lister A, Morrow CJ, Moss TA, Pink JH, Polanski R. Tricyclic Indazoles-A Novel Class of Selective Estrogen Receptor Degrader Antagonists. J Med Chem. 2019 02 14; 62(3):1593-1608. PMID: 30640465.
      View in: PubMed
    5. Nguyen HB, Chavez AM, Lipner E, Hantsoo L, Kornfield SL, Davies RD, Epperson CN. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition. Curr Psychiatry Rep. 2018 10 11; 20(12):110. PMID: 30306351.
      View in: PubMed
    6. Whitmore CA, Sakai J, Mikulich-Gilbertson SK, Davies RD. A Four-Week Reflective Writing Program in the Psychiatry Clerkship: Testing Effects on Reflective Capacity. Acad Psychiatry. 2019 Apr; 43(2):171-174. PMID: 29704195.
      View in: PubMed
    7. Scott JS, Degorce SL, Anjum R, Culshaw J, Davies RDM, Davies NL, Dillman KS, Dowling JE, Drew L, Ferguson AD, Groombridge SD, Halsall CT, Hudson JA, Lamont S, Lindsay NA, Marden SK, Mayo MF, Pease JE, Perkins DR, Pink JH, Robb GR, Rosen A, Shen M, McWhirter C, Wu D. Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma. J Med Chem. 2017 12 28; 60(24):10071-10091. PMID: 29172502.
      View in: PubMed
    8. Davies RD, Kessel B. Gender Minority Stress, Depression, and Anxiety in a Transgender High School Student. Am J Psychiatry. 2017 Dec 01; 174(12):1151-1152. PMID: 29191036.
      View in: PubMed
    9. Scott JS, Bailey A, Davies RD, Degorce SL, MacFaul PA, Gingell H, Moss T, Norman RA, Pink JH, Rabow AA, Roberts B, Smith PD. Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in Rat. ACS Med Chem Lett. 2016 Jan 14; 7(1):94-9. PMID: 26819673.
      View in: PubMed
    10. Wlochal J, Davies RD, Burton J. Cubanes in medicinal chemistry: synthesis of functionalized building blocks. Org Lett. 2014 Aug 15; 16(16):4094-7. PMID: 25068498.
      View in: PubMed
    11. McCoull W, Barton P, Brown AJ, Bowker SS, Cameron J, Clarke DS, Davies RD, Dossetter AG, Ertan A, Fenwick M, Green C, Holmes JL, Martin N, Masters D, Moore JE, Newcombe NJ, Newton C, Pointon H, Robb GR, Sheldon C, Stokes S, Morgan D. Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists. J Med Chem. 2014 Jul 24; 57(14):6128-40. PMID: 24967667.
      View in: PubMed
    12. Czyzewski M, Sellars JD, Guliashvili T, Tibbelin J, Johnstone L, Bower J, Box M, Davies RD, Ottosson H, Steel PG. The first intramolecular silene Diels-Alder reactions. Chem Commun (Camb). 2014 Mar 18; 50(22):2919-21. PMID: 24496122.
      View in: PubMed
    13. Davies RD. Wading through the flood of nontraditional therapies. J Nerv Ment Dis. 2013 Jul; 201(7):636-7. PMID: 23817162.
      View in: PubMed
    14. Barlind JG, Bauer UA, Birch AM, Birtles S, Buckett LK, Butlin RJ, Davies RD, Eriksson JW, Hammond CD, Hovland R, Johannesson P, Johansson MJ, Kemmitt PD, Lindmark BT, Morentin Gutierrez P, Noeske TA, Nordin A, O'Donnell CJ, Petersson AU, Redzic A, Turnbull AV, Vinblad J. Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). J Med Chem. 2012 Dec 13; 55(23):10610-29. PMID: 23116186.
      View in: PubMed
    15. Nazef N, Davies RD, Greaney MF. Formal synthesis of merrilactone A using a domino cyanide 1,4-addition-aldol cyclization. Org Lett. 2012 Jul 20; 14(14):3720-3. PMID: 22770228.
      View in: PubMed
    16. McCoull W, Addie MS, Birch AM, Birtles S, Buckett LK, Butlin RJ, Bowker SS, Boyd S, Chapman S, Davies RD, Donald CS, Green CP, Jenner C, Kemmitt PD, Leach AG, Moody GC, Gutierrez PM, Newcombe NJ, Nowak T, Packer MJ, Plowright AT, Revill J, Schofield P, Sheldon C, Stokes S, Turnbull AV, Wang SJ, Whalley DP, Wood JM. Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. Bioorg Med Chem Lett. 2012 Jun 15; 22(12):3873-8. PMID: 22608962.
      View in: PubMed
    17. Winhusen TM, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne S, Somoza EC. Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Oct; 21(5):455-63. PMID: 22040190.
      View in: PubMed
    18. Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, Macdonald M, Lohman M, Bailey GL, Haynes L, Jaffee WB, Haminton N, Hodgkins C, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam G, Fishman M, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu D. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry. 2011 Sep; 50(9):903-14. PMID: 21871372.
      View in: PubMed
    19. Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med. 2007 Nov; 161(11):1026-34. PMID: 17984403.
      View in: PubMed
    20. Davies RD, Thurstone C, Woyewodzic K. Substance Use Disorders and Neurologic Illness. Curr Treat Options Neurol. 2004 Sep; 6(5):421-432. PMID: 15279762.
      View in: PubMed
    21. Paterson I, Davies RD, Heimann AC, Marquez R, Meyer A. Stereocontrolled total synthesis of (-)-callipeltoside A. Org Lett. 2003 Nov 13; 5(23):4477-80. PMID: 14602029.
      View in: PubMed
    22. Riggs PD, Davies RD. A clinical approach to integrating treatment for adolescent depression and substance abuse. J Am Acad Child Adolesc Psychiatry. 2002 Oct; 41(10):1253-5. PMID: 12364848.
      View in: PubMed
    23. Davies RD, Gabbert SL, Riggs PD. Anxiety Disorders in Neurologic Illness. Curr Treat Options Neurol. 2001 Jul; 3(4):333-346. PMID: 11389804.
      View in: PubMed
    24. Davies RD, Marquez R. Total Synthesis of the Callipeltoside Aglycon We thank the EPSRC (R.D.M.D; GR/N08520), Girton College, Cambridge (R.M.), and Merck for support, and Setu P. Roday (Cambridge) for kindly assisting with the molecular modeling studies. Angew Chem Int Ed Engl. 2001 Feb 02; 40(3):603-607. PMID: 11180385.
      View in: PubMed
    25. Paterson I, Davies RDM, Marquez R. Total Synthesis of the Callipeltoside Aglycon. Angew Chem Int Ed Engl. 2001 Feb 02; 40(3):603-607. PMID: 29712021.
      View in: PubMed
    26. Davies RD, Dubovsky SL, Gabbert S, Chapman M. Treatment resistance in anxiety disorders. Bull Menninger Clin. 2000; 64(3 Suppl A):A22-36. PMID: 11002528.
      View in: PubMed
    Davies's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (117) concept(s)
    _
    Co-Authors Expand Description
    See all (12) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)